Drawing for HEALTHAI

USPTO serial 97269597

HEALTHAI

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
UKAOMA, ULOMA JANET
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HEALTHAI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher A. Proskey

Christopher A. Proskey BROWNWINICK LAW FIRM666 GRAND AVENUE, STE 2000DES MOINES, IA 50309United States

Goods and services

ClassDescriptionStatusFirst use
035Business services provided to the healthcare industry, namely, the collection, reporting, and analysis of healthcare quality data for business purposes; Collection and analysis of quality clinical and empirical data for a network of healthcare providers for business purposes; none of the foregoing services in the fields of genetics, genetics testing, or business analytics of genetics testingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 13, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 13, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 5, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 5, 2025EX1GSOU EXTENSION 1 GRANTED—
Mar 4, 2025EXT1SOU EXTENSION 1 FILED—
Mar 4, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 10, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 16, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 16, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 16, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 16, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 26, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 12, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 24, 2024RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 22, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 22, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 22, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 22, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 22, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 22, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 17, 2024RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Mar 28, 2024ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Oct 16, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 16, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Oct 16, 2023CNSLSUSPENSION LETTER WRITTEN—
Sep 7, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 7, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 7, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jun 14, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 14, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 14, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 25, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 24, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 24, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 26, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 26, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 26, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 14, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 14, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 14, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 1, 2022DOCKASSIGNED TO EXAMINER—
Feb 22, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 19, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance